Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease
暂无分享,去创建一个
J. Miyoshi | Y. Takai | S. Shibata | T. Fujita | S. Yoshida | Hirotoshi Tanaka | M. Nagase | H. Kurihara | W. Kawarazaki
[1] David A. Williams,et al. Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling , 2008, Cell.
[2] K. Suszták,et al. The Notch pathway in podocytes plays a role in the development of glomerular disease , 2008, Nature Medicine.
[3] S. Shibata,et al. Salt-Induced Nephropathy in Obese Spontaneously Hypertensive Rats Via Paradoxical Activation of the Mineralocorticoid Receptor: Role of Oxidative Stress , 2007, Hypertension.
[4] C. Esmon,et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis , 2007, Nature Medicine.
[5] Celeste M Nelson,et al. Cadherins, RhoA, and Rac1 Are Differentially Required for Stretch-Mediated Proliferation in Endothelial Versus Smooth Muscle Cells , 2007, Circulation research.
[6] M. Nangaku,et al. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression. , 2007, Kidney international.
[7] H. Kawachi,et al. Podocyte as the Target for Aldosterone: Roles of Oxidative Stress and Sgk1 , 2007, Hypertension.
[8] S. Shibata,et al. Podocyte Injury Underlies the Glomerulopathy of Dahl Salt-Hypertensive Rats and Is Reversed by Aldosterone Blocker , 2006, Hypertension.
[9] Tomoshige Kino,et al. Rho Family Guanine Nucleotide Exchange Factor Brx Couples Extracellular Signals to the Glucocorticoid Signaling System* , 2006, Journal of Biological Chemistry.
[10] S. Shibata,et al. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling. , 2006, Journal of the American Society of Nephrology : JASN.
[11] B. Teter,et al. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease , 2006, Nature Neuroscience.
[12] B. Pitt,et al. A role for mineralocorticoid receptor blockade in the prevention of apoptosis. , 2005, Journal of molecular and cellular cardiology.
[13] David A. Williams,et al. Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization , 2005, Nature Medicine.
[14] Yi Zheng,et al. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Funder. Is aldosterone bad for the heart? , 2004, Trends in Endocrinology & Metabolism.
[16] L. Ruilope,et al. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. , 2004, The American journal of cardiology.
[17] A. Hoeflich,et al. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. , 2004, Genes & development.
[18] Krister Wennerberg,et al. Rho and Rac Take Center Stage , 2004, Cell.
[19] S. Chien,et al. Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression , 2002, The EMBO journal.
[20] Rakesh Kumar,et al. P21‐activated kinase‐1 phosphorylates and transactivates estrogen receptor‐α and promotes hyperplasia in mammary epithelium , 2002, The EMBO journal.
[21] M. Lombès,et al. Alteration of Cardiac and Renal Functions in Transgenic Mice Overexpressing Human Mineralocorticoid Receptor* , 2001, The Journal of Biological Chemistry.
[22] G. Becker,et al. Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. , 2001, The New England journal of medicine.
[23] M. Garabedian,et al. Rho GTPases as Modulators of the Estrogen Receptor Transcriptional Response* , 2001, The Journal of Biological Chemistry.
[24] Y. Makino,et al. Functional modulation of the mineralocorticoid receptor by cis-diamminedichloroplatinum (II). , 2000, Kidney international.
[25] D. Vaughan,et al. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. , 2000, Kidney international.
[26] S. Nishikawa,et al. Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIα , 1999, Oncogene.
[27] D. C. Edwards,et al. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics , 1999, Nature Cell Biology.
[28] R. Barouki,et al. Modulation of human mineralocorticoid receptor function by protein kinase A. , 1999, Molecular endocrinology.
[29] James Segars,et al. Characterization of Brx, a novel Dbl family member that modulates estrogen receptor action , 1998, Oncogene.
[30] T. Sasaki,et al. Involvement of Rho and Rac small G proteins and Rho GDI in Ca2+‐dependent exocytosis from PC12 cells , 1996, Genes to cells : devoted to molecular & cellular mechanisms.
[31] Daniel Metzger,et al. Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.
[32] M. Epstein,et al. Impaired myogenic responsiveness of renal microvessels in Dahl salt-sensitive rats. , 1992, Circulation research.
[33] K. Kaibuchi,et al. Small GTP-binding proteins. , 1992, International review of cytology.
[34] C. Hall,et al. Bcr encodes a GTPase-activating protein for p21rac , 1991, Nature.